NEWTONE PHARMA LIMITEDActive
Key figures
Ratios
2024/25Balance sheet structure
Filed accounts2020/21–2024/25
| 2020/21 | 2021/22 | 2022/23 | 2023/24 | 2024/25 | |
|---|---|---|---|---|---|
| Turnover | — | — | — | 1,014,584 | 879,268 |
| Profit for the year | — | — | — | — | 32,344 |
| Cash at bank and in hand | 18,244 | — | — | 17,689 | 7,167 |
| Total assets | 77,813 | 119,503 | 109,605 | 76,935 | 66,413 |
| Total liabilities | 773,427 | 773,427 | 350,813 | 283,856 | 233,400 |
| Net assets / total equity | -695,614 | 653,924 | 241,208 | 206,921 | -166,987 |
| Average number of employees | 1 | 1 | 1 | 0 | 0 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Principal activity
Accounts 2025Wholesale of sugar and chocolate and sugar confectionery. Wholesale of pharmaceutical goods. Non-specialised wholesale trade.
As described in the company's latest filed accounts.
Summary: NEWTONE PHARMA LIMITED
Company
NEWTONE PHARMA LIMITED is a private limited company registered with Companies House under company number 08556296. It was incorporated on 5 Jun 2013. Its status is active. The registered office is in London (W1J). Its nature of business (SIC 2007) is wholesale of sugar and chocolate and sugar confectionery (46360), wholesale of pharmaceutical goods (46460), non-specialised wholesale trade (46900).
Accounts
The latest accounts in the database are for 2024/25 (period ending 30 Jun 2025); the company files small company accounts (filleted). Turnover was £879,268. Profit for the year was £32,344. Net assets were −£166,987, down 180.7% on the previous year. Cash at bank and in hand was £7,167. Total assets were £66,413 and total liabilities £233,400. The company had an average of 0 employees. Figures are available for 5 financial years (2020/21–2024/25).
Control and charges
One person with significant control is registered.
Filing deadlines
The next accounts are due by 31 Mar 2027. The next confirmation statement is due by 19 Jun 2027.